BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chasioti D, Yan J, Nho K, Saykin AJ. Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases. Trends Genet 2019;35:371-82. [PMID: 30922659 DOI: 10.1016/j.tig.2019.02.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Yashin AI, Wu D, Arbeev K, Bagley O, Akushevich I, Duan M, Yashkin A, Ukraintseva S. Interplay between stress-related genes may influence Alzheimer's disease development: The results of genetic interaction analyses of human data. Mech Ageing Dev 2021;196:111477. [PMID: 33798591 DOI: 10.1016/j.mad.2021.111477] [Reference Citation Analysis]
2 Andrews SJ, Fulton-Howard B, Patterson C, McFall GP, Gross A, Michaelis EK, Goate A, Swerdlow RH, Pa J; Alzheimer's Disease Neuroimaging Initiative. Mitonuclear interactions influence Alzheimer's disease risk. Neurobiol Aging 2020;87:138.e7-138.e14. [PMID: 31784277 DOI: 10.1016/j.neurobiolaging.2019.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zhou X, Chen Y, Ip FCF, Lai NCH, Li YYT, Jiang Y, Zhong H, Chen Y, Zhang Y, Ma S, Lo RMN, Cheung K, Tong EPS, Ko H, Shoai M, Mok KY, Hardy J, Mok VCT, Kwok TCY, Fu AKY, Ip NY. Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population. Alzheimers Dement (Amst) 2020;12:e12074. [PMID: 32775599 DOI: 10.1002/dad2.12074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nelson PT, Fardo DW, Katsumata Y. The MUC6/AP2A2 Locus and Its Relevance to Alzheimer's Disease: A Review. J Neuropathol Exp Neurol 2020;79:568-84. [PMID: 32357373 DOI: 10.1093/jnen/nlaa024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 [DOI: 10.1101/654400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs. Neuropharmacology 2020;177:108099. [PMID: 32525060 DOI: 10.1016/j.neuropharm.2020.108099] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
7 Mentink LJ, Guimarães JPOFT, Faber M, Sprooten E, Olde Rikkert MGM, Haak KV, Beckmann CF. Functional co-activation of the default mode network in APOE ε4-carriers: A replication study. Neuroimage 2021;240:118304. [PMID: 34329959 DOI: 10.1016/j.neuroimage.2021.118304] [Reference Citation Analysis]
8 Babb de Villiers C, Kroese M, Moorthie S. Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. J Med Genet 2020;57:725-32. [PMID: 32376789 DOI: 10.1136/jmedgenet-2019-106763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Najar J, van der Lee SJ, Joas E, Wetterberg H, Hardy J, Guerreiro R, Bras J, Waern M, Kern S, Zetterberg H, Blennow K, Skoog I, Zettergren A. Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives. Alzheimers Dement (Amst) 2021;13:e12142. [PMID: 33532541 DOI: 10.1002/dad2.12142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Visvikis-Siest S, Theodoridou D, Kontoe MS, Kumar S, Marschler M. Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.Front Genet. 2020;11:569175. [PMID: 33424917 DOI: 10.3389/fgene.2020.569175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 De Marco M, Manca R, Kirby J, Hautbergue GM, Blackburn DJ, Wharton SB, Venneri A, Alzheimer's Disease Neuroimaging Initiative. The Association between Polygenic Hazard and Markers of Alzheimer's Disease Following Stratification for APOE Genotype. Curr Alzheimer Res 2020;17:667-79. [PMID: 33023447 DOI: 10.2174/1567205017666201006161800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Leal LG, Hoggart C, Jarvelin MR, Herzig KH, Sternberg MJE, David A. A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin. Mol Genet Genomic Med 2020;8:e1248. [PMID: 32307928 DOI: 10.1002/mgg3.1248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Langlois CM, Bradbury A, Wood EM, Roberts JS, Kim SYH, Riviere ME, Liu F, Reiman EM, Tariot PN, Karlawish J, Langbaum JB. Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials. Alzheimers Dement (N Y) 2019;5:705-16. [PMID: 31921963 DOI: 10.1016/j.trci.2019.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
14 Kumar A, Shoai M, Palmqvist S, Stomrud E, Hardy J, Mattsson-Carlgren N, Hansson O. Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease. Sci Rep 2021;11:19853. [PMID: 34615922 DOI: 10.1038/s41598-021-99310-z] [Reference Citation Analysis]
15 Bakulski KM, Vadari HS, Faul JD, Heeringa SG, Kardia SLR, Langa KM, Smith JA, Manly JJ, Mitchell CM, Benke KS, Ware EB. Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort. Neurol Genet 2021;7:e576. [PMID: 33688582 DOI: 10.1212/NXG.0000000000000576] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ma Y, Zhou X. Genetic prediction of complex traits with polygenic scores: a statistical review. Trends Genet 2021:S0168-9525(21)00145-1. [PMID: 34243982 DOI: 10.1016/j.tig.2021.06.004] [Reference Citation Analysis]
17 Kauppi K, Rönnlund M, Nordin Adolfsson A, Pudas S, Adolfsson R. Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging. Transl Psychiatry 2020;10:250. [PMID: 32709845 DOI: 10.1038/s41398-020-00934-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
18 Ihle J, Artaud F, Bekadar S, Mangone G, Sambin S, Mariani LL, Bertrand H, Rascol O, Durif F, Derkinderen P, Scherzer C, Elbaz A, Corvol JC; DIGPD study group., Steering committee., Statistical analyses., Principal investigators for sites., Co-investigators (alphabetical order)., Neuropsychologists., Genetic core., Sponsor activities and clinical research assistants. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study. Parkinsonism Relat Disord 2020;75:30-3. [PMID: 32450545 DOI: 10.1016/j.parkreldis.2020.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Samuelsson J, Najar J, Wallengren O, Kern S, Wetterberg H, Mellqvist Fässberg M, Zetterberg H, Blennow K, Lissner L, Rothenberg E, Skoog I, Zettergren A. Interactions between dietary patterns and genetic factors in relation to incident dementia among 70-year-olds. Eur J Nutr 2021. [PMID: 34632537 DOI: 10.1007/s00394-021-02688-9] [Reference Citation Analysis]
20 Shen L, Thompson PM. Brain Imaging Genomics: Integrated Analysis and Machine Learning. Proc IEEE Inst Electr Electron Eng 2020;108:125-62. [PMID: 31902950 DOI: 10.1109/JPROC.2019.2947272] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
21 Markopoulou K, Chase BA, Premkumar AP, Schoneburg B, Kartha N, Wei J, Yu H, Epshteyn A, Garduno L, Pham A, Vazquez R, Frigerio R, Maraganore D. Variable Effects of PD-Risk Associated SNPs and Variants in Parkinsonism-Associated Genes on Disease Phenotype in a Community-Based Cohort. Front Neurol 2021;12:662278. [PMID: 33935957 DOI: 10.3389/fneur.2021.662278] [Reference Citation Analysis]
22 Qorri B, Tsay M, Agrawal A, Au R, Gracie J. Using machine intelligence to uncover Alzheimer’s disease progression heterogeneity. Exploration of Medicine 2020;1:100126. [DOI: 10.37349/emed.2020.00026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]